To generalize this observation, we examined the effect of PTP1B inhibitors, administered as a single dose, in the CLP-induced polymicrobial sepsis and LPS-induced lethal endotoxemia (sepsis) models, which recapitulate the systemic inflammation and shock-like state of bacterial septic challenge (22). Here, PTPN1 is linked to serum lipopolysaccharide activity.